OverviewSuggest Edit

Girihlet is a biotechnology company that uses T-cell sequencing for immune system monitoring. It offers ‍a platform aimed at accelerating the discovery of disease-monitoring and therapeutic strategies for immune diseases. The company provides TCR, mtDNA, RNA, whole exome/ targeted genome, microbiome, and HLA sequencing services.

Latest Updates

Employees (est.) (Jan 2021)3
Cybersecurity ratingCMore

Girihlet Financials and Metrics

Summary Metrics

Founding Date


Girihlet total Funding

$2.8 m

Girihlet latest funding size

$2.50 m

Time since last funding

2 years ago

Girihlet investors

Girihlet's latest funding round in August 2018 was reported to be $2.5 m. In total, Girihlet has raised $2.8 m
Show all financial metrics

Girihlet Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Girihlet Online and Social Media Presence

Embed Graph

Girihlet Frequently Asked Questions

  • When was Girihlet founded?

    Girihlet was founded in 2012.

  • How many employees does Girihlet have?

    Girihlet has 3 employees.

  • Who are Girihlet competitors?

    Competitors of Girihlet include Genisphere, Ring Therapeutics and Trucode Gene Repair.